THERAMetrics holding AG (SIX:TMX) announces today its financial results for 2015 Donnerstag, 21. April 2016 - 06:31

Stans, Switzerland, April 21, 2016

THERAMetrics holding AG (the "Company") today published its financial results for the year 2015. 

From both continuing and discontinued operations, THERAMetrics generated revenues of EUR 13.8 million and a net result of minus EUR 8.5 million for the year ended 31 December 2015, compared to revenues of EUR 16.2 million a net result of minus EUR 10.2 million for the year ended 31 December 2014. 

In December 2015, the Company announced its intention to exit the CRO business and, as such, presents this line of business as discontinued operations as required by International Financial Reporting Standards (IFRS). Concurrent with the announcement of the intended sale of the CRO business, the Company also announced its binding agreement to combine with Relief Therapeutics SA pending shareholder approval at the Annual General Meeting on May 25, 2016. The combined company will focus on developing its collective pipeline of promising medicinal product candidates including Aviptadil for Sarcoidosis and Low Dose Interleukin-6 (IL-6) for diabetic neuropathy. 

In conjunction with the business combination, THERAMetrics has entered into a Share Subscription Facility with GEM Global Yield Fund LLC SCS, whereby GEM undertakes to provide up to CHF 25,000,000 in liquidity over the next three years by subscribing to additional THERAMetrics shares. Details of this financing arrangement are disclosed in the 2015 Annual Report. 

The 2015 annual report is available here. 

About Therametrics holding AG
Therametrics holding AG is a global tech-based Contract Research & Development Organisation dedicated to providing a full range of technological solutions through the entire value chain of drug discovery and development. The company is listed on the SIX Swiss Exchange under the symbol TMX and is headquartered in Stans, Switzerland.

For further information please contact 
Raffaele Petrone
THERAMetrics holding AG
Investor and External Relations
T. +41 (0)44 723 59 59

investor@therametrics.com
www.therametrics.com

Media relation:
Press Area - Società & Servizi srl
mi@areacomunicazione.info

Disclaimer
This communication expressly or implicitly contains certain forward-looking statements concerning THERAMetrics holding AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of THERAMetrics holding AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. THERAMetrics holding AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.

Files:

pdf eng